...
机译:GPR110的GPCRS分析和鉴定作为HER2 +乳腺癌的潜在新靶标
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
Baylor Coll Med Dept Med Dan L Duncan Comprehens Canc Ctr Houston TX 77030 USA;
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
Univ Texas Hlth Sci Ctr Houston Inst Mol Med Houston TX 77030 USA;
Baylor Coll Med Lester &
Sue Smith Breast Ctr Houston TX 77030 USA;
Baylor Coll Med Lester &
Sue Smith Breast Ctr Houston TX 77030 USA;
Baylor Coll Med Lester &
Sue Smith Breast Ctr Houston TX 77030 USA;
Baylor Coll Med Lester &
Sue Smith Breast Ctr Houston TX 77030 USA;
Baylor Coll Med Lester &
Sue Smith Breast Ctr Houston TX 77030 USA;
Univ Texas Hlth Sci Ctr Houston Inst Mol Med Houston TX 77030 USA;
Baylor Coll Med Dept Med Dan L Duncan Comprehens Canc Ctr Houston TX 77030 USA;
Baylor Coll Med Dept Med Dan L Duncan Comprehens Canc Ctr Houston TX 77030 USA;
Univ Houston Dept Pharm Practice &
Translat Res 4849 Calhoun St Houston TX 77204 USA;
GPR110; HER2; Breast cancer; Drug resistance; Drug targets; Tumorigenesis;
机译:GPR110的GPCRS分析和鉴定作为HER2 +乳腺癌的潜在新靶标
机译:蛋白转录组分析的231 BR乳腺癌细胞:潜在的生物标志物和脑转移治疗目标的鉴定。
机译:食道鳞状细胞癌中的癌症-睾丸基因表达谱:鉴定特定的肿瘤标志物和免疫治疗的潜在靶标。
机译:药物靶标鉴定和药物分析的化学策略方法 - CDK12 / CCNK作为BIO0919278的潜在目标
机译:抑制Ape1的DNA修复活性作为癌症靶标:鉴定具有翻译潜力的新型小分子,可用于分子靶向癌症治疗
机译:GPCR分析和鉴定GPR110作为HER2 +乳腺癌的潜在新靶标
机译:GPR110的GPCRS分析和鉴定作为HER2 +乳腺癌的潜在新靶标
机译:前景:评估胸部癌症和治疗靶标识别的抗性模式和致癌信号通路的分析。